Navigation Links
Anti-Convulsant Aids Knee-Replacement Patients
Date:10/15/2007

Pregabalin reduced pain, increased range of motion, study found

MONDAY, Oct. 15 (HealthDay News) -- The anti-convulsant drug pregabalin, given before and after surgery, helped reduce pain and promote mobility in patients having total knee replacement.

That study finding was presented Sunday at the annual meeting of the American Society of Anesthesiologists, in San Francisco.

The study, funded by drug maker Pfizer Inc., included 60 total knee replacement patients who were divided into two groups. One group received 300 milligrams of pregabalin two hours before surgery and 150 mg twice a day for 14 days after surgery. Patients in the other group received a placebo.

All the patients received pain medication through an epidural catheter during surgery and through a patient-controlled device after surgery.

In the 32 hours after surgery, patients who received pregabalin reported lower levels of pain and used less pain medication. Patients in the pregabalin group also had a higher range of knee motion when they were discharged from the hospital -- 84 degrees versus 76 degrees for patients in the placebo group. A knee-motion range of at least 83 degrees is required to climb stairs.

"When you can walk up and down stairs, it makes a huge difference in patient quality of life," and improved range of motion also promotes quicker completion of post-surgery rehabilitation, said study author Dr. Asokumar Buvanendran, director of orthopedic anesthesia and associate professor of anesthesiology at Rush University Medical Center in Chicago.

More information

The American Academy of Orthopaedic Surgeons has more about total knee replacement.



-- Robert Preidt



SOURCE: American Society of Anesth
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Mode Of Action Of The Anti-Convulsant Valproate
2. One in Three Heart Attack Patients Have No Chest Pains
3. Amphetamines Help Recovery of Stroke Patients
4. Painkillers Do Not Shorten Dying Patients Lives
5. Patients With Filariasis More Prone To HIV Infection
6. Glivec - New Hope For CMC Patients
7. HIV infected patients can travel safely abroad
8. New vaccine helps allergy and asthma patients
9. Doctors operate upon patients in candlelight- latest from the quake scene
10. New vaccine helps allergy and asthma patients
11. Are cancer patients being taken for a ride?
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2Health News:Antidepressants May Change Your Personality 2Health News:Antidepressants May Change Your Personality 3Health News:Antidepressants May Change Your Personality 4Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 2Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 3Health News:Workforce Alliance Earns Grant to Train Health Care Workers 2Health News:Workforce Alliance Earns Grant to Train Health Care Workers 3
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3UC Davis study highlights work life issues of female surgeons 52395 1UC Davis study highlights work life issues of female surgeons 52395 2Fecal incontinence and quality of life 52393 1Early rice harvests ease annual famine in Bangladesh 9316 1Early rice harvests ease annual famine in Bangladesh 9316 2